Chemical Works of Gedeon Richter Plc (RGEDF)
41.60
+0.90
(+2.21%)
USD |
OTCM |
Nov 16, 16:00
Chemical Works of Gedeon Richter Price to Book Value : 1.708 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.708 |
| November 13, 2026 | 1.671 |
| November 12, 2026 | 1.689 |
| November 11, 2026 | 1.616 |
| November 10, 2026 | 1.630 |
| November 09, 2026 | 1.641 |
| November 06, 2026 | 1.621 |
| November 05, 2026 | 1.672 |
| November 04, 2026 | 1.682 |
| November 03, 2026 | 1.644 |
| November 02, 2026 | 1.657 |
| October 30, 2026 | 1.590 |
| October 29, 2026 | 1.681 |
| October 28, 2026 | 1.531 |
| October 27, 2026 | 1.684 |
| October 26, 2026 | 1.691 |
| October 23, 2026 | 1.66 |
| October 22, 2026 | 1.618 |
| October 21, 2026 | 1.618 |
| October 20, 2026 | 1.635 |
| October 19, 2026 | 1.627 |
| October 16, 2026 | 1.610 |
| October 15, 2026 | 1.586 |
| October 14, 2026 | 1.559 |
| October 13, 2026 | 1.582 |
| Date | Value |
|---|---|
| October 12, 2026 | 1.575 |
| October 09, 2026 | 1.524 |
| October 08, 2026 | 1.467 |
| October 07, 2026 | 1.478 |
| October 06, 2026 | 1.582 |
| October 05, 2026 | 1.557 |
| October 02, 2026 | 1.574 |
| October 01, 2026 | 1.576 |
| September 30, 2026 | 1.606 |
| September 29, 2026 | 1.623 |
| September 28, 2026 | 1.630 |
| September 25, 2026 | 1.658 |
| September 24, 2026 | 1.625 |
| September 23, 2026 | 1.632 |
| September 22, 2026 | 1.719 |
| September 21, 2026 | 1.756 |
| September 18, 2026 | 1.720 |
| September 17, 2026 | 1.739 |
| September 16, 2026 | 1.682 |
| September 15, 2026 | 1.648 |
| September 14, 2026 | 1.683 |
| September 11, 2026 | 1.652 |
| September 10, 2026 | 1.718 |
| September 09, 2026 | 1.704 |
| September 08, 2026 | 1.705 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 12.06 |
| ANI Pharmaceuticals, Inc. | 2.548 |
| Corcept Therapeutics, Inc. | 9.080 |
| Veru, Inc. | 1.250 |
| Avadel Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PE Ratio | 10.05 |
| PS Ratio | 2.586 |
| PEG Ratio | 0.4485 |
| Price to Free Cash Flow | 9.450 |
| Price | 41.60 |
| Earnings Yield | 9.95% |
| Market Cap | 7.616B |
| PEGY Ratio | 0.3646 |
| Operating PE Ratio | 7.285 |
| Normalized PE Ratio | 10.05 |